Opentrons Labworks has unveiled its Compliance Ready Software (Opentrons CRS) for the Opentrons Flex® robotic platform, designed to facilitate regulatory compliance in laboratory settings. This software aligns with U.S. FDA Title 21 CFR Part 11 standards, offering essential features like authentication, signed audit trails, and role-based access, all while maintaining a significantly lower total cost of ownership compared to traditional GxP systems.
The introduction of Opentrons CRS comes at a time when regulatory demands for electronic record integrity are increasing within the pharmaceutical and biotech sectors. Laboratories often face the dilemma of choosing between costly automation solutions that meet compliance standards and more accessible platforms that do not. Opentrons aims to bridge this gap, allowing laboratories to automate processes without compromising on regulatory requirements.
Key features of Opentrons CRS include system-level electronic record integrity, irreversible per-robot activation for compliance-ready states, and local data retention managed directly by the labs. This software is tailored for non-GMP regulated environments, making it suitable for a range of applications, from pharmaceutical research to medical device development.
Scheduled for debut at SLAS Europe 2026, Opentrons CRS will be available for one-on-one demonstrations, showcasing its capabilities in maintaining compliance while streamlining laboratory workflows. This launch may significantly impact how laboratories approach automation, potentially leading to more efficient and compliant operations in the life sciences sector.